Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 105.00%22.58K | 100.96%1.93K | -321.08%-6.53K | 105.85%29.67K | 98.67%-2.49K | 15.23%-451.41K | -134.04%-200.87K | -100.13%-1.55K | -233.57%-506.81K | 94.38%-187.93K |
| Net income from continuing operations | 41.10%-8.53M | 38.14%-7.23M | -7.65%-549.61K | 61.30%-221.19K | 58.79%-527.49K | 45.81%-14.48M | 46.08%-11.69M | 68.54%-510.57K | -611.14%-571.53K | 63.42%-1.28M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 161.32%387.54K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -26.76%336.69K | -149.46%-59.74K | 115.11%115.28K | --111.36K | -11.19%169.79K | -73.38%459.7K | -86.00%120.78K | -75.91%53.59K | --0 | -45.72%191.19K |
| Asset impairment expenditure | -41.53%5.58M | ---- | ---- | ---- | ---- | -36.85%9.55M | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | --87.97K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non cashItems | -16.96%1.26M | 134.14%560.37K | -50.89%187.48K | -46.45%193.11K | -31.81%316.64K | -45.26%1.51M | -91.27%239.33K | -32.50%381.74K | 235.91%360.62K | 46.34%464.38K |
| Change In working capital | -39.30%1.29M | 17.70%1.06M | 145.83%240.33K | 81.88%-53.61K | -93.63%38.57K | -62.96%2.12M | -67.19%901.5K | -95.36%97.76K | -135.61%-295.91K | 1,556.95%605.15K |
| -Change in receivables | -103.49%-30.82K | -120.16%-41.27K | 202.25%88.1K | ---61.02K | -104.91%-16.63K | -61.98%883.28K | 172.42%204.65K | -102.13%-86.16K | ---- | --338.48K |
| -Change in prepaid assets | -80.80%7.88K | --0 | 0.00%2.63K | --2.63K | -92.17%2.63K | -93.95%41.01K | -99.99%125 | 100.38%2.63K | ---- | --33.55K |
| -Change in payables and accrued expense | 9.57%1.31M | 58.22%1.1M | -17.48%149.61K | --4.79K | -77.45%52.58K | -56.07%1.19M | 11.28%696.72K | 114.49%181.3K | ---- | --233.12K |
| Interest paid (cash flow from operating activities) | ---- | ---- | --0 | --0 | --0 | --0 | 170.46%290.01K | 60.62%-23.98K | ---- | ---168.78K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 105.00%22.58K | 100.96%1.93K | -349.90%-6.53K | 105.85%29.67K | 98.67%-2.49K | 15.23%-451.41K | -114.96%-200.87K | -100.12%-1.45K | -233.57%-506.81K | 94.38%-187.93K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -106.21%-14.86K | -96.89%10.8K | 0 | -25.66K | 0 | 102.73%239.44K | 117.06%347.17K | 0 | 0 | 95.62%-85.23K |
| Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | --0 | 125.25%107.73K | 95.13%-107.73K | --0 | 89.23%-85.23K |
| Net PPE purchase and sale | -106.21%-14.86K | -96.89%10.8K | --0 | ---25.66K | --0 | 115.12%239.44K | --347.17K | --0 | ---- | ---85.23K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -106.21%-14.86K | -96.89%10.8K | --0 | ---25.66K | --0 | 102.73%239.44K | 117.06%347.17K | --0 | --0 | 95.62%-85.23K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 0 | -94.32%159.25K | -124.88%-134.82K | 0 | 551.29%613.86K | 121.73%262.25K |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | -110.22%-180K | ---180K | --0 | --0 | --0 |
| Net common stock issuance | --0 | --0 | ---- | ---- | ---- | -55.48%357K | -92.15%62.93K | ---319.79K | 61,385,900.00%613.86K | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -9.43%-17.75K | ---- | ---- | ---- | --262.25K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --0 | --0 | -94.32%159.25K | -124.88%-134.82K | --0 | 551.29%613.86K | 121.73%262.25K |
| Net cash flow | ||||||||||
| Beginning cash position | -79.19%13.85K | 272.58%8.85K | 301.91%15.37K | -79.59%11.36K | -79.19%13.85K | -98.99%66.57K | -98.91%2.37K | -97.03%3.83K | -17.46%55.66K | -98.99%66.57K |
| Current changes in cash | 114.65%7.73K | 10.93%12.73K | -349.90%-6.53K | 107.48%4.01K | 77.17%-2.49K | 99.19%-52.72K | 107.62%11.48K | -101.64%-1.45K | -187.68%-53.66K | 99.83%-10.91K |
| End cash Position | 55.77%21.58K | 55.77%21.58K | 272.58%8.85K | 666.73%15.37K | -79.59%11.36K | -79.19%13.85K | -79.19%13.85K | -98.91%2.37K | -98.44%2.01K | -17.46%55.66K |
| Free cash from | 101.51%7.73K | 108.28%12.73K | -349.90%-6.53K | 100.79%4.01K | 99.09%-2.49K | 91.08%-511.97K | 76.99%-153.7K | 99.86%-1.45K | -356.98%-506.81K | 93.41%-273.16K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.